Stocks
REGENXBIO (RGNX) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.0% | -216.7% | -265.4% | -237.9% | -85.4% | -267.8% | ||
| Changes by years, y/y, % | +99pp | -253pp | -49pp | +27pp | +152pp | +6.4% | |||
REGENXBIO. EBITDA margin, %
REGENXBIO. EBITDA margin, changes, pp
REGENXBIO (RGNX) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 20.9% | -262.1% | -151.0% | -168.1% | -1 304% | -267.8% | |
| Changes by years, y/y, % | +387pp | -45pp | +76pp | +10pp | -1 325pp | |||
| Changes by quarters, q/q, % | +199pp | -283pp | +111pp | -17pp | -1 136pp | |||
